Scientists have found a system of priming the bodyâ€™s immune system to recognise, attack and kill off cancerous cells in lung, skin and bowel tumours .
Early trials have shown survival rates were boosted by more than 50 per cent .
Scientists are now recruiting patients with skin cancer for the first human trial on humans .